Biofourmis Inc.
6
0
1
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
33.3%
2 terminated/withdrawn out of 6 trials
50.0%
-36.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Serum Potassium Prediction Using Machine Learning and Single-lead ECG
Role: collaborator
Prediction of 30-Day Readmission Using Machine Learning
Role: collaborator
Prediction of Expected Length of Hospital Stay Using Machine Learning
Role: collaborator
Prediction of Patient Deterioration Using Machine Learning
Role: collaborator
Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors
Role: lead
Kardia - A Smartphone-based Care Model for Outpatient Cardiac Rehabilitation
Role: collaborator
All 6 trials loaded